Correlation of Non–High-Density Lipoprotein Cholesterol and Low-Density Lipoprotein Cholesterol With Apolipoprotein B During Simvastatin + Fenofibrate Therapy in Patients With Combined Hyperlipidemia (A Subanalysis of the SAFARI Trial)

Correlations between non-HDL cholesterol and ApoB and LDL cholesterol and ApoB in mITT population. Correlations in simvastatin 20-mg treatment group for non-HDL cholesterol and ApoB at baseline (A) and after 12 weeks of treatment (B) and for LDL cholesterol and ApoB at baseline (C) and after 12 weeks of treatment (D). Correlations in simvastatin 20-mg plus fenofibrate 160-mg treatment group for non-HDL cholesterol and ApoB at baseline (E) and after 12 weeks of treatment (F) for LDL cholesterol and ApoB at baseline (G) and after 12 weeks of treatment (H).